Surgery, Gastroenterology and Oncology

Introduction: In this study were included patients with liver cirrhosis waiting for liver transplantation. The study aims were to assess the prevalence and predictors of decreased muscle mass which is a frequent finding in liver cirrhosis associated with a poor prognosis.

Material and Method: The study included 133 patients with liver cirrhosis, who were splited into two groups, low and high, based on their psoas muscle index (PMI). The PMI was calculated using the area of the psoas muscle measured on CT or MRI images andmore]

Background: Non-alcoholic fatty liver disease (NAFLD) and cirrhosis represent significant global health concerns, often diagnosed through invasive methods like liver biopsy. Identifying non-invasive biomarkers for these conditions could greatly enhance early detection and management. Objective: To evaluate the relationship between Procalcitonin (PCT) and Mean Platelet Volume (MPV) levels and hepatic steatosis in patients with NAFLD and cirrhosis.

Methods: a case-control study included 133 participants divided into N....[more]

Background: Treatment of complex perianal fistula (cPF) in Crohn’s Disease (CD) constitutes a major challenge for gastroenterologists and surgeons. The aim of this study is to review the experience of a tertiary reference centre and identify prognostic factors related to non-response to treatment.

Methods: Retrospective cohort study of adult patients with CD operated on for cPF, in a

tertiary reference centre, from January 2015 to June 2023 and followed up until December 2023. Characteristics of ....[more]

Background: Patients with abdominal cancers may present with advanced disease either locally or metastatic and so, accurate staging help in selection of the appropriate treatment plan (curative or palliative). Up to 50% of patients diagnosed with colorectal cancers (CRC) and 40% of patients diagnosed with pancreatic cancers will have  metastatic hepatic lesions during the course of the disease, where 7% of patents with CRC and 14% of patients with advanced gastric cancers will develop peritoneal metastases. Despite advances in pre-operative imaging used for d....[more]